Kimia Biosciences Ltd is in the business of Pharmaceutical productsProduct Profile: Company manufactures Active Pharmaceuticals Ingredients. It has commercialized 25+ products with 9-10 molecules under development
Kimia Biosciences has announced a certificate from its Registrar and Share Transfer Agent confirming that all securities submitted for dematerialization during the quarter were processed and updated in the depository system. Physical share certificates received were verified, mutilated, and canceled, with ownership records duly transferred to depositories within 15 days....
KIMIA BIOSCIENCES LIMITED has clarified that recent share price movements are driven by market conditions and investor activity, with no undisclosed material information impacting the stock. The company confirms all necessary disclosures have been made and remains committed to transparency, assuring shareholders there are no pending announcements affecting the share...
Kimia Biosciences has announced a board meeting to consider the financial results for the quarter and half-year. The company has also informed shareholders about an Extraordinary General Meeting (EGM) to be conducted through video conferencing at its corporate office, with e-voting facilities provided for member participation. This update ensures shareholders...
Kimia Biosciences Limited has announced a board meeting to hold an Extraordinary General Meeting (EGM) through video conferencing. Key agenda items include regularizing M/S Neeraj Arora & Associates as the statutory auditors, filling the casual vacancy after the earlier auditor’s resignation, and appointing Mr. Prasad Raju as a Director liable...
Kimia Biosciences Limited has announced a board meeting on July 22 for an Extra-Ordinary General Meeting (EGM) to be held via video conferencing. Shareholders will be able to vote electronically, with remote e-voting open from July 19 to July 21. The company has set a cut-off date for voting eligibility...
